| Ticker Details |
|
Viridian Therapeutics, Inc.
|
| IPO Date: |
June 16, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.9B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.51 | 2.75%
|
| Avg Daily Range (30 D): |
$0.36 | 2.23%
|
| Avg Daily Range (90 D): |
$0.58 | 2.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
2.59M |
| Avg Daily Volume (90 D): |
2.05M |
| Trade Size |
| Avg Trade Size (Sh.): |
70 |
| Avg Trade Size (Sh.) (30 D): |
83 |
| Avg Trade Size (Sh.) (90 D): |
79 |
| Institutional Trades |
| Total Institutional Trades: |
2,329 |
| Avg Institutional Trade: |
$2.18M |
| Avg Institutional Trade (30 D): |
$2.4M |
| Avg Institutional Trade (90 D): |
$2.97M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.16M |
| Avg Closing Trade (30 D): |
$5.12M |
| Avg Closing Trade (90 D): |
$6.02M |
| Avg Closing Volume: |
157.42K |
|
|
| News |
May 17, 2026 @ 6:32 PM
This Biotech Has a June 30 FDA Catalyst. A Fund Ju...
Source: Jonathan Ponciano
|
Apr 21, 2026 @ 7:26 PM
Kopp Family Office Trims $3.5 Million Worth of Vir...
Source: Andy Gould
|
Apr 1, 2026 @ 5:53 PM
J.Jill, Inc. Shareholders Are Encouraged to Reach ...
Source: Johnson Fistel, Pllp
|
Mar 31, 2026 @ 3:00 PM
Viridian Therapeutics, Inc. Shareholders Are Encou...
Source: Johnson Fistel, Pllp
|
Feb 23, 2026 @ 3:26 PM
Viridian Therapeutics Stock Up 75%, but One Fund J...
Source: Jonathan Ponciano
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
|
|
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$.14M
|
$.13M
|
$70.85M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-104.9M
|
$-120.36M
|
$-342.6M
|
|
Operating Income / Loss
|
$-116.17M
|
$-122.75M
|
$-363.4M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-36.04M
|
$42.74M
|
$112.79M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Nov 13, 2020
|
1:15
|
|
Nov 07, 2016
|
1:15
|
|
|
|
